Cleared Traditional

K792039 - WILLIAM HARVEY H-1500 BLOOD OXYGENATOR

K792039 is the FDA 510(k) clearance for WILLIAM HARVEY H-1500 BLOOD OXYGENATOR by C.R. Bard, Inc.. It is a Class 2 Cardiovascular device (product code DTZ) cleared through the Traditional 510(k) pathway after a 18-day FDA review.

K792039 · C.R. Bard, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1979
Decision
18d
Days
Class 2
Risk

K792039 is an FDA 510(k) clearance for the WILLIAM HARVEY H-1500 BLOOD OXYGENATOR. Classified as Oxygenator, Cardiopulmonary Bypass (product code DTZ), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Mchenry, US). The FDA issued a Cleared decision on October 30, 1979 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4350 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K792039 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 12, 1979
Decision Date October 30, 1979
Days to Decision 18 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
107d faster than avg
Panel avg: 125d · This submission: 18d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DTZ Oxygenator, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4350
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DTZ Oxygenator, Cardiopulmonary Bypass

All 191
Devices cleared under the same product code (DTZ) and FDA review panel - the closest regulatory comparables to K792039.
SPIRAFLO BLOOD OXYGENATORS MODEL BOS-10S
K802719 · Bentley Laboratories, Inc. · Dec 1980
SPIRAFLO BLOOD OXYGENATORS MODEL BOS-5S
K802720 · Bentley Laboratories, Inc. · Dec 1980
BUILT-IN TEMPERATURE MONITORING
K801240 · Bentley Laboratories, Inc. · Jun 1980
OXYGENATOR, COBE CATALOG #42-220
K790356 · Cobe Laboratories, Inc. · Mar 1979
OXYGENATOR, BLOOD BOS-10
K781842 · Bentley Laboratories, Inc. · Nov 1978
OXYGENATOR, BUBBLE TYPE
K780078 · Bentley Laboratories, Inc. · Sep 1978